The Long and Short of Disability

 

Depending on your condition and treatment regimen, you may need to take some time off from work. It is important to learn about short-term and long-term disability insurance plans that may be available to you. These plans can each cover a percentage of your salary if you can't work because of an illness or disability. But the long and short of it is, they each have their own rules.

Short-term disability insurance plans—There are two types of short-term plans: (1) a private policy that is offered through your employer or purchased on your own, and (2) state-sponsored policies. Five states—California, Hawaii, New Jersey, New York, and Rhode Island—and Puerto Rico currently have short-term disability insurance plans for employees, according to the U.S. Chamber of Commerce. Plans differ from state to state. They may begin as soon as 1 weeks' time and last up to 1 year. Contact your state’s insurance department for more information.

Long-term disability insurance plans—These plans can be private policies offered through your employer or purchased on your own. In addition, there are two long-term plans that are administered by the federal government. They usually start when short-term disability benefits end. Long-term disability benefits typically replace 60 percent to 70 percent of your income. You have to be qualified as disabled for 1 year or more to qualify. Contact your state’s insurance department or the Social Security Administration for more information.

Latest Cancer News
ACOG Updates Cervical Cancer Screening Guidelines

November 20, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.

New Velcade®-melphalan Transplant Regimen for Multiple Myeloma

November 20, 2009 — Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.

Folic Acid May Be Beneficial in Patients with Recurrent Colorectal Adenoma Who Are Folate Deficient

November 20, 2009 — Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.

Select news items provided by Reuters Health